Tseligka ED - Search Results

1

Heparan Sulfate Proteoglycans and Viral Attachment: True Receptors or Adaptation Bias?

Cagno V, Tseligka ED, Jones ST, Tapparel C. Cagno V, et al. Among authors: tseligka ed. Viruses. 2019 Jul 1;11(7):596. doi: 10.3390/v11070596. Viruses. 2019. PMID: 31266258 Free PMC article. Review.

2

Antiviral drug screening by assessing epithelial functions and innate immune responses in human 3D airway epithelium model.

Boda B, Benaoudia S, Huang S, Bonfante R, Wiszniewski L, Tseligka ED, Tapparel C, Constant S. Boda B, et al. Among authors: tseligka ed. Antiviral Res. 2018 Aug;156:72-79. doi: 10.1016/j.antiviral.2018.06.007. Epub 2018 Jun 8. Antiviral Res. 2018. PMID: 29890184 Free PMC article.

3

A VP1 mutation acquired during an enterovirus 71 disseminated infection confers heparan sulfate binding ability and modulates ex vivo tropism.

Tseligka ED, Sobo K, Stoppini L, Cagno V, Abdul F, Piuz I, Meylan P, Huang S, Constant S, Tapparel C. Tseligka ED, et al. PLoS Pathog. 2018 Aug 3;14(8):e1007190. doi: 10.1371/journal.ppat.1007190. eCollection 2018 Aug. PLoS Pathog. 2018. PMID: 30075025 Free PMC article.

4

Growth of Zika virus in human reconstituted respiratory, intestinal, vaginal and neural tissues.

Cagno V, Tseligka ED, Bettex Q, Huang S, Constant S, Tapparel C. Cagno V, et al. Among authors: tseligka ed. Clin Microbiol Infect. 2019 Aug;25(8):1042.e1-1042.e4. doi: 10.1016/j.cmi.2019.04.016. Epub 2019 May 8. Clin Microbiol Infect. 2019. PMID: 31075547 Free article.

5

HDV Pathogenesis: Unravelling Ariadne's Thread.

Tseligka ED, Clément S, Negro F. Tseligka ED, et al. Viruses. 2021 Apr 28;13(5):778. doi: 10.3390/v13050778. Viruses. 2021. PMID: 33924806 Free PMC article. Review.

6

Variant enterovirus A71 found in immune-suppressed patient binds to heparan sulfate and exhibits neurotropism in B-cell-depleted mice.

Weng KF, Tee HK, Tseligka ED, Cagno V, Mathez G, Rosset S, Nagamine CM, Sarnow P, Kirkegaard K, Tapparel C. Weng KF, et al. Among authors: tseligka ed. Cell Rep. 2023 Apr 25;42(4):112389. doi: 10.1016/j.celrep.2023.112389. Epub 2023 Apr 13. Cell Rep. 2023. PMID: 37058406 Free PMC article.

7

ANGPTL4 is a potential driver of HCV-induced peripheral insulin resistance.

Gomes D, Sobolewski C, Conzelmann S, Schaer T, Lefai E, Alfaiate D, Tseligka ED, Goossens N, Tapparel C, Negro F, Foti M, Clément S. Gomes D, et al. Among authors: tseligka ed. Sci Rep. 2023 Apr 25;13(1):6767. doi: 10.1038/s41598-023-33728-5. Sci Rep. 2023. PMID: 37185283 Free PMC article.

8

Identification of selective hepatitis delta virus ribozyme inhibitors by high-throughput screening of small molecule libraries.

Tseligka ED, Conzelmann S, Cambet Y, Schaer T, Negro F, Clément S. Tseligka ED, et al. JHEP Rep. 2022 Dec 17;5(3):100652. doi: 10.1016/j.jhepr.2022.100652. eCollection 2023 Mar. JHEP Rep. 2022. PMID: 36704052 Free PMC article.

9

Biocompatible Zr-based nanoscale MOFs coated with modified poly(ε-caprolactone) as anticancer drug carriers.

Filippousi M, Turner S, Leus K, Siafaka PI, Tseligka ED, Vandichel M, Nanaki SG, Vizirianakis IS, Bikiaris DN, Van Der Voort P, Van Tendeloo G. Filippousi M, et al. Among authors: tseligka ed. Int J Pharm. 2016 Jul 25;509(1-2):208-218. doi: 10.1016/j.ijpharm.2016.05.048. Epub 2016 May 26. Int J Pharm. 2016. PMID: 27235556

10

Development and Pharmacological Evaluation of New Bone-Targeted (99m)Tc-Radiolabeled Bisphosphonates.

Makris G, Tseligka ED, Pirmettis I, Papadopoulos MS, Vizirianakis IS, Papagiannopoulou D. Makris G, et al. Among authors: tseligka ed. Mol Pharm. 2016 Jul 5;13(7):2301-17. doi: 10.1021/acs.molpharmaceut.6b00081. Epub 2016 May 31. Mol Pharm. 2016. PMID: 27170456

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page